✦ LIBER ✦

Commentary on “Challenges to demonstrating disease-modifying effects in Alzheimer’s disease clinical trials”

✍ Scribed by Paul S. Aisen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Challenges to demonstrating disease-modi

✍ Jeffrey L. Cummings 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Preclinical and clinical challenges in t

✍ Carol A Scorer 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 130 KB

AMPA workshop on challenges faced by inv

✍ Bruno Vellas; Alain Pesce; Philippe H. Robert; Paul S. Aisen; Sonia Ancoli-Israe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Commentary on “Health economics and the

✍ Rebecca E. Ready 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Challenges in clinical research on Alzhe

✍ Ronald C. Petersen 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Commentary on “Optimal design of clinica

✍ Eric R. Siemers 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 71 KB